Osamu Ogawa
#137,593
Most Influential Person Now
Osamu Ogawa's AcademicInfluence.com Rankings
Osamu Ogawaphilosophy Degrees
Philosophy
#7029
World Rank
#10176
Historical Rank
Logic
#4107
World Rank
#5357
Historical Rank

Osamu Ogawabiology Degrees
Biology
#9529
World Rank
#12744
Historical Rank
Genetics
#977
World Rank
#1073
Historical Rank
Molecular Biology
#1321
World Rank
#1348
Historical Rank

Download Badge
Philosophy Biology
Osamu Ogawa's Degrees
- PhD Molecular Biology University of Tokyo
- Doctorate Medicine University of Tokyo
Why Is Osamu Ogawa Influential?
(Suggest an Edit or Addition)Osamu Ogawa's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour (1993) (724)
- Gene expression levels and immunolocalization of organic ion transporters in the human kidney. (2002) (504)
- Risk Factors for Prostate Cancer (2004) (404)
- Salt-sensitive hypertension in circadian clock–deficient Cry-null mice involves dysregulated adrenal Hsd3b6 (2010) (380)
- Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. (2007) (378)
- Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. (2006) (347)
- Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. (1995) (324)
- Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population (2010) (293)
- Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. (2001) (199)
- Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. (2000) (195)
- Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. (2020) (191)
- Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases (2020) (191)
- Collagenous matrices as release carriers of exogenous growth factors. (2004) (190)
- Mosaic and polymorphic imprinting of the WT1 gene in humans (1994) (174)
- Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine (2004) (171)
- Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient. (2005) (165)
- Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. (2000) (165)
- Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus (2014) (156)
- Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. (2004) (150)
- Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. (1997) (150)
- Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. (1995) (146)
- Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. (2002) (143)
- Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. (1991) (142)
- Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. (1993) (122)
- Transperitoneal laparoscopic adrenalectomy: experience in 100 patients. (1997) (121)
- XISTunmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer (2004) (118)
- Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. (2004) (117)
- Constitutional relaxation of insulin–like growth factor II gene imprinting associated with Wilms' tumour and gigantism (1993) (116)
- Type I collagen can function as a reservoir of basic fibroblast growth factor. (2004) (116)
- Accumulated allelic losses in the development of invasive urothelial cancer (1993) (116)
- A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. (2006) (110)
- Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm (2012) (109)
- Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese (2012) (107)
- Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer (2008) (107)
- Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan (2018) (105)
- Overexpression of human mutT homologue gene messenger RNA in renal‐cell carcinoma: Evidence of persistent oxidative stress in cancer (1996) (103)
- Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. (2005) (103)
- Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. (1994) (102)
- Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor. (2003) (97)
- STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma. (2007) (96)
- Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells (2004) (94)
- Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism (2003) (93)
- Clinical and molecular features of treatment‐related neuroendocrine prostate cancer (2018) (93)
- Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination. (2002) (91)
- Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. (2003) (89)
- Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. (2009) (88)
- The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. (2003) (88)
- Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics. (2012) (88)
- Human insulin-like growth factor type I and type II receptors are not imprinted. (1993) (87)
- Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. (2010) (86)
- Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population. (2005) (83)
- Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer. (2008) (82)
- Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. (2008) (81)
- Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. (1991) (81)
- Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer. (2006) (81)
- Escherichia coli Isolates Associated with Uncomplicated and Complicated Cystitis and Asymptomatic Bacteriuria Possess Similar Phylogenies, Virulence Genes, and O-Serogroup Profiles (2006) (81)
- Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors. (2001) (79)
- Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer (2008) (78)
- Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin. (2000) (76)
- Expression Levels of Renal Organic Anion Transporters (OATs) and Their Correlation with Anionic Drug Excretion in Patients with Renal Diseases (2004) (76)
- Development of Japanese version of the UCLA Prostate Cancer Index: a pilot validation study (2002) (76)
- Development of a Multiplex RNA Urine Test for the Detection and Stratification of Transitional Cell Carcinoma of the Bladder (2008) (75)
- Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin. (2001) (73)
- Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma (1999) (73)
- Current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP. (2007) (72)
- Chronobiology of micturition: putative role of the circadian clock. (2013) (71)
- Exposure–Toxicity Relationship of Sorafenib in Japanese Patients with Renal Cell Carcinoma and Hepatocellular Carcinoma (2014) (70)
- Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma (2008) (70)
- Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer (2001) (70)
- Thioredoxin-interacting protein suppresses bladder carcinogenesis. (2011) (68)
- 176: Soluble Substances from Bladder Smooth Muscle Cells Induce Smooth Muscle Cell-Like Phenotype in Bone Marrow Stromal Cells (2004) (66)
- Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population. (2003) (65)
- Efficacy of nondrug lifestyle measures for the treatment of nocturia. (2010) (65)
- Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein. (2006) (65)
- Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP protein. (2001) (62)
- Allelic Frequency of p53 Gene Codon 72 Polymorphism in Urologic Cancers (1995) (61)
- P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. (2007) (60)
- Septins as diagnostic markers for a subset of human asthenozoospermia. (2008) (59)
- The presence of the virulence island containing the usp gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model. (2001) (59)
- The Expression Profile of Phosphatidylinositol in High Spatial Resolution Imaging Mass Spectrometry as a Potential Biomarker for Prostate Cancer (2014) (59)
- Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. (2003) (59)
- Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin. (2008) (59)
- Precise comparison of protein localization among OCT, OAT, and MATE in human kidney. (2013) (58)
- Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. (2002) (58)
- Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells. (2007) (57)
- ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma. (2010) (57)
- Efficient gene transfer by pullulan-spermine occurs through both clathrin- and raft/caveolae-dependent mechanisms. (2006) (57)
- Patient-derived xenografts as in vivo models for research in urological malignancies (2017) (57)
- Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer. (2000) (56)
- Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis. (2004) (56)
- Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. (2004) (56)
- Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite. (2007) (56)
- Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice. (2004) (55)
- Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications (2017) (54)
- Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy. (2006) (54)
- Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer (2015) (54)
- Increased biofilm formation in Escherichia coli isolated from acute prostatitis. (2006) (53)
- Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype. (1992) (53)
- Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy‐naïve castration‐resistant prostate cancer: The Kyoto‐Baltimore collaboration (2017) (52)
- Ultrasound Enhancement of In Vitro Transfection of Plasmid DNA by a Cationized Gelatin (2002) (52)
- Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. (2003) (52)
- Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan (2000) (52)
- The importance of integrin‐linked kinase in the regulation of bladder cancer invasion (2012) (52)
- Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan. (2009) (51)
- Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision (2020) (51)
- A novel tumor‐related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma (2007) (51)
- Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. (2003) (50)
- Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines (2006) (50)
- Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species. (2007) (50)
- Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma. (2001) (50)
- Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. (2002) (49)
- Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer (2013) (49)
- TRAIL and chemotherapeutic drugs in cancer therapy. (2004) (49)
- Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. (2003) (49)
- A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial (2017) (49)
- Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer (2019) (49)
- Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic‐specific protein: Comparison with phylogenetic groups (2006) (48)
- Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells. (2006) (48)
- CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia. (2005) (47)
- Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population (2008) (47)
- Prognostic significance of HIF‐1α polymorphisms in transitional cell carcinoma of the bladder (2008) (47)
- Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney (2008) (46)
- The abnormal occurrence and the differentiation‐dependent distribution of N‐acetyl and N‐glycolyl species of the ganglioside GM2 in human germ cell tumors a study with specific monoclonal antibodies (1990) (46)
- Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. (2006) (46)
- Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model (2013) (46)
- Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide. (2013) (45)
- Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients (2010) (45)
- Enhancement of TRAIL/Apo2L‐mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells (2003) (45)
- Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder. (2008) (45)
- Seasonal alterations in nocturia and other storage symptoms in three Japanese communities. (2007) (45)
- Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population (2008) (45)
- Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer. (1998) (43)
- Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1. (2007) (43)
- Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone (2019) (43)
- Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan (1999) (42)
- A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression. (2010) (42)
- Methylation-associated silencing of SFRP1 in renal cell carcinoma. (2008) (42)
- Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle. (2009) (42)
- Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. (2002) (41)
- Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. (1992) (41)
- CCL2 as a potential therapeutic target for clear cell renal cell carcinoma (2016) (41)
- Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population. (2003) (41)
- Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1. (1994) (41)
- Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1‐Mb interval on 8p22 (1999) (41)
- Distribution of the usp Gene in Uropathogenic Escherichia coli Isolated from Companion Animals and Correlation with Serotypes and Size‐Variations of the Pathogenicity Island (2003) (40)
- Lansoprazole—Tacrolimus Interaction in Japanese Transplant Recipient with CYP2C19 Polymorphism (2004) (40)
- Evaluation for Surrogacy of End Points by Using Data from Observational Studies: Tumor Downstaging for Evaluating Neoadjuvant Chemotherapy in Invasive Bladder Cancer (2006) (40)
- Enhanced expression of plasmid DNA-cationized gelatin complex by ultrasound in murine muscle. (2002) (40)
- Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo. (2010) (39)
- Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder. (2008) (39)
- Methylation-associated silencing of TU3A in human cancers. (2008) (39)
- Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism (2018) (39)
- Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. (2001) (38)
- Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil. (2001) (38)
- Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan. (2014) (38)
- Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab (2020) (38)
- In Vitro Transfection of Plasmid DNA by Amine Derivatives of Gelatin Accompanied with Ultrasound Irradiation (2002) (38)
- Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. (2004) (37)
- Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft (2010) (37)
- 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population (2019) (37)
- Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer (2013) (37)
- Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma (2002) (37)
- Laparoscopic partial nephrectomy using microwave tissue coagulator for small renal tumors: usefulness and complications. (2004) (36)
- Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma. (2007) (36)
- Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. (2009) (35)
- IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility. (2012) (35)
- The Effect of ABCG2 Genotype on the Population Pharmacokinetics of Sunitinib in Patients With Renal Cell Carcinoma (2014) (35)
- Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men (2007) (35)
- Night‐time frequency, sleep disturbance and general health‐related quality of life: Is there a relation? (2009) (34)
- Contribution of Chromosome 9p21‐22 Deletion to the Progression of Human Renal Cell Carcinoma (1995) (34)
- Regulation of androgen receptor transactivity and mTOR–S6 kinase pathway by Rheb in prostate cancer cell proliferation (2010) (34)
- High incidence of urinary bladder involvement in carcinomas of the sigmoid and rectum: A retrospective review of 580 patients with colorectal carcinoma (2003) (34)
- Changing concepts of bladder regeneration (2007) (34)
- Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer. (2019) (34)
- Discrepancy between local and central pathological review of radical prostatectomy specimens. (2009) (34)
- High 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report (2005) (33)
- Fluorescent imaging of high‐grade bladder cancer using a specific antagonist for chemokine receptor CXCR4 (2009) (33)
- Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3β with p53 (2008) (33)
- Defective Jak–Stat activation in renal cell carcinoma is associated with interferon‐α resistance (2007) (33)
- A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. (1993) (32)
- Authentic role of ATP signaling in micturition reflex (2016) (32)
- Microsatellite polymorphism of steroid hormone synthesis gene CYP11A1 is associated with advanced prostate cancer (2004) (32)
- Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer. (2007) (32)
- Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: A preliminary study (2004) (32)
- Dicoumarol enhances doxorubicin‐induced cytotoxicity in p53 wild‐type urothelial cancer cells through p38 activation (2010) (31)
- Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers (2003) (31)
- Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival (2015) (31)
- Reproducibility, Performance, and Clinical Utility of a Genetic Risk Prediction Model for Prostate Cancer in Japanese (2012) (31)
- Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. (1998) (31)
- Genetic polymorphisms in glutathione S-transferase T1 affect the surgical outcome of varicocelectomies in infertile patients. (2009) (31)
- Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (2015) (31)
- Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY. (2004) (30)
- Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients (2004) (30)
- Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel. (2007) (30)
- Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient. (2007) (30)
- A Survey of the FAERS Database Concerning the Adverse Event Profiles of α1-Adrenoreceptor Blockers for Lower Urinary Tract Symptoms (2013) (30)
- STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma. (2013) (30)
- Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas (2003) (29)
- [The Japanese translation and cultural adaptation of Expanded Prostate Cancer Index Composite (EPIC)]. (2005) (29)
- Differences and associations between nocturnal voiding/nocturia and sleep disorders (2009) (29)
- Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance. (2009) (29)
- Low incidence of ipsilateral adrenal involvement and recurrences in patients with renal cell carcinoma undergoing radical nephrectomy: a retrospective analysis of 393 patients. (2003) (29)
- Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. (2007) (29)
- Intravital imaging of mouse urothelium reveals activation of extracellular signal‐regulated kinase by stretch‐induced intravesical release of ATP (2016) (29)
- Tumor targeting of gene expression through metal-coordinated conjugation with dextran. (2003) (29)
- Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. (2000) (28)
- Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series (2002) (27)
- Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume. (1997) (27)
- RBM10–TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break‐apart fluorescence in‐situ hybridisation: study of 10 cases and a literature review (2019) (27)
- Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a japanese population (2004) (26)
- Perioperative Antimicrobial Prophylaxis in Urology: a Multi-Center Prospective Study (2005) (26)
- The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. (2006) (26)
- An EP4 Antagonist ONO-AE3-208 Suppresses Cell Invasion, Migration, and Metastasis of Prostate Cancer (2014) (26)
- Multipoint methylation and expression analysis of tumor suppressor genes in human renal cancer cells. (2003) (26)
- Altered Detrusor Gap Junction Communications Induce Storage Symptoms in Bladder Inflammation: A Mouse Cyclophosphamide-Induced Model of Cystitis (2014) (26)
- A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort (2016) (26)
- Infrequent ras Mutation in Human Stomach Cancers (1993) (26)
- Fabrication of an Optimal Urethral Graft Using Collagen-Sponge Tubes Reinforced with Copoly(L-Lactide/ε-Caprolactone) Fabric (2007) (25)
- Comparison of the effectiveness of ET-Kyoto with Euro-Collins and University of Wisconsin solutions in cold renal storage (2002) (25)
- Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance. (2007) (25)
- Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies (2019) (25)
- [A multi-center prospective study for antibiotic prophylaxis to prevent perioperative infections in urologic surgery]. (2004) (25)
- p53 and chemosensitivity in bladder cancer (2008) (25)
- Lectin-reactive α-Fetoprotein (AFP-L3%) Curability and Prediction of Clinical Course after Treatment of Non-seminomatous Germ Cell Tumors (2002) (25)
- Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma (2019) (25)
- Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study (2010) (25)
- Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells. (2009) (24)
- CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population. (2005) (24)
- Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen. (2006) (24)
- Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy (2007) (24)
- Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer. (2015) (23)
- Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers (2007) (23)
- Long-term functional outcomes of ileal and sigmoid orthotopic neobladder procedures. (2006) (23)
- Anaphylaxis following administration of intravenous methylprednisolone sodium succinate in a renal transplant recipient (2004) (23)
- A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection. (2010) (23)
- Successful laparoscopic management of chylous ascites following laparoscopic radical nephrectomy (2006) (23)
- B‐type natriuretic peptide as an independent correlate of nocturnal voiding in Japanese women (2012) (23)
- Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan. (2008) (23)
- SPA‐1 controls the invasion and metastasis of human prostate cancer (2011) (23)
- An Accessory Spleen Mimicking a Nonfunctional Adrenal Tumor: A Potential Pitfall in the Diagnosis of a Left Adrenal Tumor (2000) (22)
- Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology (2019) (22)
- A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor. (2011) (22)
- Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era. (2013) (21)
- Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: An open‐label study (2010) (21)
- GSTT1 and GSTM1 polymorphisms are associated with improvement in seminal findings after varicocelectomy. (2005) (21)
- Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges (2018) (21)
- Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A (2017) (21)
- Evidence‐based clinical practice guidelines for bladder cancer (Summary – JUA 2009 Edition) (2010) (21)
- Sleep Disturbance Worsens Lower Urinary Tract Symptoms: The Nagahama Study. (2019) (20)
- Regulation of connexin 43 by basic fibroblast growth factor in the bladder: transcriptional and behavioral implications. (2011) (20)
- Factors predicting efficacy and adverse effects of enzalutamide in Japanese patients with castration-resistant prostate cancer: results of retrospective multi-institutional study (2016) (20)
- Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity. (1995) (20)
- Detection of alpha-fetoprotein mRNA in seminoma. (1999) (20)
- Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features (1998) (20)
- A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer (2008) (20)
- Elevation of serum transforming growth factor-β1 Level in patients with metastatic prostate cancer. (1996) (19)
- The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan (2004) (19)
- Antibiotic prophylaxis for transrectal prostate biopsy: A prospective randomized study of tosufloxacin versus levofloxacin (2008) (19)
- JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma (2012) (19)
- Surgical treatment for urethral recurrence after ileal neobladder reconstruction in patients with bladder cancer (2006) (19)
- The novel tumor‐suppressor Mel‐18 in prostate cancer: Its functional polymorphism, expression and clinical significance (2009) (19)
- Circadian coordination of ATP release in the urothelium via connexin43 hemichannels (2018) (19)
- ‘Trifecta’ outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study (2019) (19)
- Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching (2018) (19)
- Percentage of positive biopsy cores, preoperative prostate‐specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi‐institutional outcome study in Japan (2006) (19)
- Association of a genetic polymorphism of the E-cadherin gene with prostate cancer in a Japanese population. (2005) (19)
- A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor. (2010) (19)
- Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer. (2004) (19)
- Two Target Regions of Allelic Loss on Chromosome 9 in Urinary‐bladder Cancer (1999) (18)
- Constitutive activation of the 41‐ and 43‐kDa mitogen‐activated protein (MAP) kinases in the progression of prostate cancer to an androgen‐independent state (2005) (18)
- Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma. (2004) (18)
- The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. (2005) (18)
- Non‐secretor status is associated with female acute uncomplicated pyelonephritis (2002) (18)
- Equivalent Parental Distribution of Frequently Lost Alleles and Biallelic Expression of the H19 Gene in Human Testicular Germ Cell Tumors (1996) (18)
- Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper (2020) (18)
- Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study (2013) (18)
- Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer (2018) (17)
- Cross‐Sectional Epidemiological Analysis of the Nagahama Study for Correlates of Overactive Bladder: Genetic and Environmental Considerations (2017) (17)
- Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort (2019) (17)
- Reduced-dose docetaxel for castration-resistant prostate cancer has no inferior impact on overall survival in Japanese patients (2013) (17)
- No association between HER‐2 gene polymorphism at codon 655 and a risk of bladder cancer (2002) (17)
- Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy (1999) (17)
- Testicular thecoma in an 11-year-old boy with nevoid basal-cell carcinoma syndrome (Gorlin syndrome). (2010) (17)
- Epithelial stromal tumor of the seminal vesicle (2006) (17)
- High-resolution HLA-DRB1 and DQB1 genotyping in Japanese patients with testicular germ cell carcinoma. (1997) (17)
- Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation (2007) (17)
- Objective patterning of uroflowmetry curves in children with daytime and nighttime wetting. (2010) (17)
- Role of mammalian target of rapamycin inhibitor in the treatment of metastatic epithelioid angiomyolipoma: A case report (2013) (17)
- Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis (2013) (16)
- In vitro transfection of plasmid DNA by different-cationized gelatin with or without ultrasound irradiation (2001) (16)
- Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples (2016) (16)
- Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy (2014) (16)
- Role of Rev‐erbα domains for transactivation of the connexin43 promoter with Sp1 (2013) (16)
- Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer (2011) (16)
- Overexpression of ETS-1 is associated with malignant biological features of prostate cancer. (2012) (16)
- Up‐regulation of miR‐582‐5p regulates cellular proliferation of prostate cancer cells under androgen‐deprived conditions (2014) (15)
- Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer. (2009) (15)
- Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors. (2006) (15)
- A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population (2014) (15)
- Distribution of afaE adhesins in Escherichia coli isolated from Japanese patients with urinary tract infection. (2003) (15)
- Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti‐angiogenic therapy (2012) (15)
- Development of diurnal micturition pattern in mice after weaning. (2013) (15)
- The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1) (2013) (15)
- 697O A phase III, randomized, open-label study of first-line durvalumab (D) with or without tremelimumab (T) vs standard of care chemotherapy in patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE) (2020) (15)
- Failure of ureteric bud invasion: a new model of renal agenesis in mice. (2001) (15)
- Correlation of initial PSA level and biopsy features with PSA-doubling time in early stage prostate cancers in Japanese men. (2002) (15)
- Prevalence of postmicturition urinary incontinence in Japanese men: Comparison with other types of incontinence (2013) (14)
- Per‐operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate‐specific antigen era (2000) (14)
- Age‐associated increase of prostate‐specific antigen in a high level of men visiting urological clinics (2005) (14)
- [Effects of ischemia on voiding function and nerve growth factor of the rat urinary bladder]. (1999) (14)
- Bowel perforation by a peritoneal dialysis catheter: report of two cases (2017) (14)
- The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients (2019) (14)
- Amino‐terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer (2017) (14)
- Prostate specific antigen nadir determined using ultra‐sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males (2007) (14)
- Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line (2001) (14)
- Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR (2021) (14)
- Comparative evaluation of the extraction and analysis of urinary phospholipids and lysophospholipids using MALDI-TOF/MS. (2019) (14)
- Impact of Nocturia on Mortality: The Nagahama Study. (2020) (14)
- Clinical significance of polymorphism and expression of chromogranin a and endothelin-1 in prostate cancer. (2010) (14)
- RECENT ADVANCES IN THE MOLECULAR GENETICS OF UROGENITAL TUMORS (1994) (13)
- Significance of elevated preoperative α‐fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors (2006) (13)
- The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer (2014) (13)
- Longitudinal Analysis of Bidirectional Relationships Between Nocturia and Depressive Symptoms: The Nagahama Study. (2019) (13)
- Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma (2020) (13)
- Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer (2005) (13)
- [Small cell carcinoma of the bladder]. (2014) (13)
- Association of the PIG3 promoter polymorphism with invasive bladder cancer in a Japanese population. (2006) (12)
- Clinical implications of the MDM 2 SNP 309 and p 53 Arg 72 Pro polymorphisms in transitional cell carcinoma of the bladder (12)
- Impact of the objective response to and number of cycles of platinum‐based first‐line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab (2021) (12)
- Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models (2007) (12)
- Good prognosis of cellular mesoblastic nephroma with hyperdiploidy and relaxation of imprinting of the maternal IGF2 gene. (1995) (12)
- MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway. (2015) (12)
- A multi-center study of pediatric uroflowmetry data using patterning software. (2013) (11)
- Laparoscopic Adrenalectomy for Bilateral Pheochromocytoma: A Case Report (1997) (11)
- Differences between bothersome and non‐bothersome night‐time frequency (2007) (11)
- Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis. (2019) (11)
- Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort (2021) (11)
- Population Pharmacokinetics of Everolimus in Relation to Clinical Outcomes in Patients With Advanced Renal Cell Carcinoma (2016) (11)
- Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched‐pair comparison in a multicenter cohort in Japan (2020) (11)
- Atypical true hermaphroditism with a mosaic 45,X/46,X,dic(Y) (q11.2) karyotype. (1998) (11)
- Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer (2005) (11)
- CXCL1 is elevated in the urine of bladder cancer patients (2015) (11)
- Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes. (2013) (11)
- 5‐year interval change in voiding function of orthotopic ileal neobladder (2006) (11)
- Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer (2016) (11)
- Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma. (2014) (11)
- Risk factors predicting the outcome of salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy (2013) (11)
- [National trend of management of benign prostatic hyperplasia in Japan during 1990s: analysis of national health statistics]. (2000) (11)
- Fabrication of an optimal urethral graft using collagen-sponge tubes reinforced with Copoly(L-lactide/epsilon-caprolactone) fabric. (2007) (11)
- Docetaxel‐based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration‐resistant prostate cancer: Long‐term outcomes (2019) (10)
- The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial (2017) (10)
- Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors. (2002) (10)
- BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors. (2001) (10)
- Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation (2019) (10)
- BALB/c-Fcgr2b−/−Pdcd1−/− mouse expressing anti-urothelial antibody is a novel model of autoimmune cystitis (2012) (10)
- Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma. (2019) (10)
- Increased intracellular doxorubicin by anti-FAS monoclonal antibody: a mechanism that enhances the cytotoxicity in renal cell carcinoma cells. (2001) (10)
- Consecutive Prostate Cancer Specimens Revealed Increased Aldo–Keto Reductase Family 1 Member C3 Expression with Progression to Castration-Resistant Prostate Cancer (2019) (10)
- PTHrP is endogenous relaxant for spontaneous smooth muscle contraction in urinary bladder of female rat. (2013) (10)
- Follow‐up of clinical stage I testicular cancer patients: Cost and risk benefit considerations (2002) (10)
- Decision Analysis for Treatment of Early Stage Prostate Cancer (1998) (10)
- Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan (2013) (10)
- An original patient‐derived xenograft of prostate cancer with cyst formation (2016) (10)
- Laparoendoscopic single-site surgery for left adrenalectomy: standardization of technique. (2011) (10)
- Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort (2020) (10)
- Predictive value of radiological response rate for pathological response to neoadjuvant chemotherapy and post-cystectomy survival of bladder urothelial cancer. (2016) (10)
- Effective and Safe Administration of Low-Dose Estramustine Phosphate for Castration-Resistant Prostate Cancer. (2016) (10)
- Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma. (2018) (9)
- Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma (2019) (9)
- Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells (2007) (9)
- Furosemide versus Gosha‐Jinki‐Gan, a Blended Herbal Medicine, for Nocturnal Polyuria: A Randomized Crossover Trial (2012) (9)
- Augmented Reality Navigation System for Robot-Assisted Laparoscopic Partial Nephrectomy (2017) (9)
- Purine‐rich element binding protein (PUR) α induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells (2009) (9)
- Retroperitoneoscopic treatment of caliceal diverticular calculi: report of two cases and review of the literature. (2004) (9)
- Clinical evaluation of serum p53 antibodies in patients with upper urinary tract tumors. (2005) (9)
- CCL 2 as a potential therapeutic target for clear cell renal cell carcinoma (2019) (9)
- Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: Causative factors affecting sensitivity and specificity. (1997) (9)
- Gliding Basal Cell Migration of the Urothelium during Wound Healing. (2018) (9)
- Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance (2018) (9)
- Sequential Use of Androgen Receptor Axis-targeted Agents in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Retrospective Analysis With 3-Year Follow-up. (2019) (9)
- Clinical Significance of Varicocelectomy for Male Infertility (2000) (9)
- Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer (2021) (9)
- Clinical Significance of Nonpalpable Prostate Cancer with Favorable Biopsy Features in Japanese Men (2000) (9)
- Laser-capture microdissection for analysis of cell type-specific gene expression of muscarinic receptor subtypes in the rat bladder with cyclophosphamide-induced cystitis (2015) (9)
- Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short‐term Luteinizing Hormone‐releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate‐risk Prostate Cancer: Preliminary Prospective Study (2017) (9)
- University of California at Los Angeles Prostate Cancer Index (UCLA PCI) 日本語版作成の試み (2002) (9)
- Urethral mobility at catheter removal predicts early recovery of urinary continence after radical prostatectomy (2009) (9)
- Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer (2016) (8)
- Underweight body mass index is a risk factor of mortality in outpatients with nocturia in Japan (2015) (8)
- High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer (2021) (8)
- Asia prostate cancer study (A-CaP Study) launch symposium (2016) (8)
- Feasibility of laparoscopic adrenalectomy for metastatic adrenal tumors in selected patients: a retrospective multicenter study of Japanese populations (2019) (8)
- The clinical utility of measuring total PSA, PSA density, gamma-seminoprotein and gamma-seminoprotein/total PSA in prostate cancer prediction. (2000) (8)
- Prognosis of metastatic renal cell carcinoma with first‐line interferon‐α therapy in the era of molecular‐targeted therapy (2016) (8)
- Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan (2019) (8)
- A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer (2016) (8)
- Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model (2020) (8)
- Dietary Sodium Restriction Reduces Nocturnal Urine Volume and Nocturnal Polyuria Index in Renal Allograft Recipients With Nocturnal Polyuria. (2017) (8)
- A phase III, randomized, open-label, multicenter, global study of first-line durvalumab plus standard of care (SoC) chemotherapy and durvalumab plus tremelimumab, and SoC chemotherapy versus SoC chemotherapy alone in unresectable locally advanced or metastatic urothelial cancer (NILE). (2021) (8)
- Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors (2018) (8)
- Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice (2013) (8)
- Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity. (2007) (8)
- Synergy of Interferon-α and 5-Fluorouracil in Human Renal Cell Carcinoma Requires p53 Activity (2007) (7)
- A case of primary urethral lymphoma presenting as a huge mass surrounding the female urethra. (1997) (7)
- Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched‐pair analysis in a multicenter cohort (2021) (7)
- Large scale genome-wide association study in a Japanese population identified 45 novel susceptibility loci for 22 diseases (2019) (7)
- Late recurrence of nonseminomatous germ cell tumor successfully treated with intensity-modulated radiation therapy. (2013) (7)
- High incidence of BK virus‐associated hemorrhagic cystitis in children after second or third allogeneic hematopoietic stem cell transplantation (2018) (7)
- Molecular diagnosis of metastatic origin in a patient with metachronous multiple cancers of the renal pelvis and bladder. (2000) (7)
- Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer. (2019) (7)
- Renal scarring is associated with nonsecretion of blood type antigen in children with primary vesicoureteral reflux. (2005) (7)
- Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology (2019) (7)
- A polymorphism of the POLG2 gene is genetically associated with the invasiveness of urinary bladder cancer in Japanese males (2011) (7)
- The Clinical Utility of Measuring Total PSA , PSA Density , γ-Seminoprotein and γ-Seminoprotein / Total PSA in Prostate Cancer Prediction (2000) (7)
- The Short-Term Impact of Dietary Counseling on Sodium Intake and Blood Pressure in Renal Allograft Recipients (2016) (6)
- Retroperitoneoscopic ureterocalicostomy for congenital proximal ureteral stenosis. (2004) (6)
- SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization (2021) (6)
- A family case with germline TSC1 and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis (2018) (6)
- The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer (2021) (6)
- eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA (2019) (6)
- [A case of myxoid liposarcoma in the right inguinal region: a case report]. (2006) (6)
- Trp53 mutation in Krt5-expressing basal cells facilitates the development of basal squamous-like invasive bladder cancer in the chemical carcinogenesis of mouse bladder. (2020) (6)
- Adult‐onset idiopathic hypogonadotropic hypogonadism presented with erectile and ejaculatory disorder (2002) (6)
- High incidence of urological complications in men dying from prostate cancer (2016) (6)
- Initial evaluation of PET/CT with 18F‐FSU‐880 targeting prostate‐specific membrane antigen in prostate cancer patients (2019) (6)
- Ratio of prostate specific antigen minor molecular forms-to-total prostate specific antigen is constant regardless of the pathological condition of the prostate. (2003) (6)
- Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score (2013) (6)
- Establishment and characterization of a novel treatment‐related neuroendocrine prostate cancer cell line KUCaP13 (2021) (6)
- Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment (2015) (6)
- Detection of von Hippel‐Lindau gene mutation in circulating cell‐free DNA for clear cell renal cell carcinoma (2021) (6)
- Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional study. (2016) (6)
- Management of concomitant ureteral carcinoma in situ at radical cystectomy (2006) (6)
- Immunocytochemical Detection of p53 in Cultures of Exfoliated Cells from Urine of Patients with Urothelial Cancers (1996) (6)
- Narrative review of challenges in the management of advanced neuroendocrine prostate cancer (2021) (6)
- [Translation and adaptation of the UCLA prostate cancer index for use in Japan]. (2002) (6)
- Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy? (2005) (6)
- LacdiNAc-Glycosylated Prostate-specific Antigen Density is a Potential Biomarker of Prostate Cancer. (2019) (6)
- First report of idiopathic segmental ureteritis successfully treated by steroid therapy (2012) (6)
- Preoperative diagnosis of congenital segmental giant megaureter presenting as a fetal abdominal mass. (2010) (6)
- Evaluation of Calvert's formula for dosage adjustment of carboplatin in Japanese patients with hormone refractory prostate cancer. (2006) (6)
- Retroperitoneoscopic ureterocutaneostomy for obstructive uropathy with advanced bladder cancer: A case report (2002) (5)
- High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers (2006) (5)
- Successful treatment of primary aldosteronism due to computed tomography‐negative microadenoma (2003) (5)
- High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers. (2006) (5)
- [Clinical Characteristics of Prostate Ductal Adenocarcinoma in Kyoto University Hospital]. (2015) (5)
- Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy (2019) (5)
- TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer (2019) (5)
- Expression of parathyroid hormone/parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles: a clinico-pathological study (2015) (5)
- Results of radiation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: comparison of two different definitions of PSA failure (2006) (5)
- [A case of malignant fibrous histiocytoma arising from the renal capsule]. (2001) (5)
- The 2nd conference on Asian trends in prostate cancer hormone therapy. (2003) (5)
- [Bilateral maxillary sinus metastasis of renal cell carcinoma: a case report]. (2007) (5)
- Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching. (2021) (5)
- [A case of vaginal metastasis of transitional cell carcinoma]. (2004) (5)
- [Well-differentiated inflammatory liposarcoma occurring in the scrotum: a case report]. (2006) (5)
- Clinical feasibility and acceptability of adding cognitive behavioral therapy to pharmacotherapy for drug‐resistant overactive bladder in women: A single‐arm pilot study (2020) (4)
- Solitary upper ureteral malakoplakia successfully diagnosed by ureteroscopic biopsy and treated conservatively (2007) (4)
- Medical history of nocturnal enuresis during school age is an independent risk factor for nocturia in adults: The Nagahama study (2020) (4)
- Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer (2010) (4)
- Development of Japanese Version of the UCLA Prostate Cancer Index (2002) (4)
- [Sperm cryopreservation for cancer patients: 5-year experience in a private hospital in Japan]. (2009) (4)
- Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder (2006) (4)
- [Solitary fibrous tumor in the pelvic space: a case report]. (2007) (4)
- Association of XRCC 1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors (4)
- Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome (2017) (4)
- [One year follow-up results of urinary incontinence and sexual function after holmium laser enucleation of the prostate]. (2009) (4)
- Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients. (2006) (4)
- Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy. (2016) (4)
- The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy. (2004) (4)
- Add‐on effects of tadalafil in tamsulosin‐treated patients with small benign prostatic enlargement: A randomized, placebo‐controlled, double‐blind, crossover study (2020) (4)
- Cognitive behavioral therapy for overactive bladder in women: study protocol for a randomized controlled trial (2020) (4)
- [A case of ureteral malignant lymphoma with concentric thickening of the ureteral wall]. (2012) (4)
- [Prostate cancer with penile metastasis: a case report]. (2005) (4)
- Urothelium-Specific Deletion of Connexin43 in the Mouse Urinary Bladder Alters Distension-Induced ATP Release and Voiding Behavior (2021) (4)
- Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort (2019) (4)
- Sonodynamic Effect of Polyethylene glycol-conjugated Fullerene on Tumor (2002) (4)
- Successful renal transplantation for end‐stage renal insufficiency developed in a patient with Castleman's disease (2013) (4)
- Telomerase activity in urine after transurethral resection is not a predictive marker for recurrence of superficial bladder cancer (2003) (4)
- Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non-Muscle-Invasive Bladder Cancer in Real-World Clinical Practice. (2019) (4)
- A phase III, multicenter, randomized, controlled study of maximum androgen blockade with versus without zoledronic acid in treatment-naïve prostate cancer patients with bone metastases: Results of ZAPCA study. (2015) (4)
- High‐grade and hormone‐treated prostate cancer express high levels of thymidylate synthase (2006) (4)
- [Pseudomyxoma peritonei arising from urachal carcinoma]. (2013) (3)
- [Usefulness of ultrasound-guided prostate biopsy in the diagnosis and treatment of localized prostate cancer]. (1996) (3)
- ANDROGEN RECEPTOR GENE ABERRATIONS IN CIRCULATING CELL FREE DNA FROM JAPANESE CASTRATION RESISTANT PROSTATE CANCER PATIENTS: MP29‐05 (2018) (3)
- Cavernous Nerve Graft Reconstruction with a Novel Artificial Conduit during Robot-Assisted Laparoscopic Radical Prostatectomy (2015) (3)
- The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancers (2013) (3)
- Three‐dimensional simulation analysis of microdissection testicular sperm extraction for patients with non‐obstructive azoospermia (2020) (3)
- Data processing on a comparative evaluation of the extraction and analysis procedures for urinary phospholipid and lysophospholipid using MALDI-TOF/MS (2019) (3)
- [Epidemiological survey of sexually transmitted male urethritis in Kyoto Prefecture]. (2006) (3)
- Sensitization of human renal cell carcinoma cell lines to TRAIL‐induced apoptosis by anthracyclines (2004) (3)
- [Cross-cultural validated adaptation of dysfunctional voiding symptom score (DVSS) to Japanese language and cognitive linguistics in questionnaire for pediatric patients]. (2014) (3)
- Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer (2018) (3)
- [Testicular Leydig cell tumor presenting as male infertility: a case report]. (2009) (3)
- [Disruption of genomic imprinting in human carcinogenesis]. (1996) (3)
- Adult wilms tumor in the renal pelvis: case report with review of the literature. (2008) (3)
- 329 ERG ONCOPROTEIN EXPRESSION IN LOCALIZED PROSTATE CANCER IN JAPANESE POPULATION (2012) (3)
- [Marked improvement of cardiac function following renal transplantation: a case report]. (2003) (3)
- [Retroperitoneal ganglioneuroma presenting as a soft tissue mass surrounding the aorta: report of a case]. (2005) (3)
- [A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma]. (2019) (3)
- Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer: case series study. (2014) (3)
- Sperm cryopreservation: Clinical and fertility outcomes in male oncological patients with germ cell tumors or hematological disorders (2018) (3)
- Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer. (2020) (3)
- [The role of ATP-receptor in controlling the urinary bladder and urethral function in rats]. (1999) (3)
- The MET proto-oncogene is not a major target for the gain of chromosome 7 in testicular germ-cell tumors of adolescents (2004) (3)
- 285TiP DANUBE: A Phase 3 randomised study of first-line durvalumab (MEDI4736) ± tremelimumab vs standard of care (SoC) chemotherapy (CT) in patients (pts) with Stage IV urothelial carcinoma (UC) (2016) (3)
- Late relapse of testicular cancer 21 years after first complete remission: a case report. (2008) (3)
- Intravesical prostatic protrusion is not always the same shape: Evaluation by preoperative cystoscopy and outcome in HoLEP (2018) (3)
- Rapid semen identification from mixed body fluids using methylation-sensitive high-resolution melting analysis of the DACT1 gene. (2020) (3)
- [Impact of different methods of estimating renal function on determining eligibility for cisplatin (CDDP)-based chemotherapy in patients with invasive urothelial carcinoma]. (2011) (3)
- Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires. (2020) (3)
- [Ultrasound-guided renal cyst puncture and 95% ethanol instillation. Part 2: Morphological and functional alterations]. (1984) (3)
- Functional and genomic characterization of patient‐derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma (2020) (3)
- Guideline Adherence of Immediate Post‐Transurethral Resection Intravesical Chemotherapy for Patients with Nonmuscle Invasive Bladder Cancer (2016) (3)
- Development of a Novel Tool for Assessing Deformation and Hardness of Real Organs: Pressure Measuring Grasper (PMEG) (2016) (3)
- Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer (2020) (3)
- Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer (2018) (3)
- Modification of Platinum-based Systemic Chemotherapy for Advanced Urothelial Carcinoma in Patients With Suboptimal Renal Function (2021) (3)
- Retroperitoneoscopic nephrectomy as a second-line treatment after transarterial embolization for symptomatic autosomal dominant polycystic kidney disease. (2006) (3)
- [A Case of Thyroid-Like Follicular Carcinoma of the Kidney]. (2017) (3)
- [Indication of varicocelectomy for the treatment of male infertility]. (2004) (2)
- A functional variant in NKX 3 . 1 associated with prostate cancer susceptibility down-regulates NKX 3 . 1 expression (2010) (2)
- [Post-operative recurrence patterns of urothelial tumors in the upper urinary tract: comparison between renal pelvic and ureteral tumors]. (2008) (2)
- Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy in Japanese patients with locally advanced prostate cancer (2010) (2)
- Outcomes of High-Dose Whole-Pelvic IMRT With Simultaneous Integrated Boost in Patients With Pelvic Lymph Node–Positive Prostate Cancer (2015) (2)
- Enhancement of transduction efficiency using Adeno-associated viral vectors by chemical pretreatment to mice bladder urothelium. (2020) (2)
- A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer (2018) (2)
- Association of vitamin D receptor gene polymorphism with protection against prostate cancer and benign prostate hyperplasia (1999) (2)
- [Multiple chromophobe renal cell carcinoma: a case report]. (2010) (2)
- Current topics and perspectives in bladder cancer research (2008) (2)
- Image Overlay Support with 3DCG Organ Model for Robot-Assisted Laparoscopic Partial Nephrectomy (2016) (2)
- GENETIC PROFILES OF FLUOROQUINOLONE-RESISTANT ESCHERICHIA COLI ISOLATED FROM CYSTITIS: PHYLOGENY, VIRULENCE, PAIUSP-SUBTYPES, AND MUTATION PATTERNS (2009) (2)
- Re: Comprehensive Molecular Characterization of Muscle-invasive Bladder Cancer. (2017) (2)
- [Advanced Adenocarcinoma of the Bladder after Augmentation Gastrocystoplasty]. (2016) (2)
- [Human prostatic tissue specific antigens: a model for the research of monoclonal antibodies against unknown antigens]. (1993) (2)
- [Novel treatment for prostate cancer targeting prostaglandins]. (2014) (2)
- [Questionnaire survey in Japan for sperm cryopreservation before chemotherapy ]. (2008) (2)
- 197: Prostate Cancer Screening Strategies with Rescreening Interval Determined by Individual Baseline Prostate-Specific Antigen Values are Cost-Effective (2007) (2)
- Transition in Type of Surgery for Benign Prostatic Hyperplasia: A Multi‐institutional Study in Japan (2011) (2)
- Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy (2022) (2)
- [A case of renal subcapsular cyst successfully treated with endoscopic ultrasound-guided transgastric drainage of pancreatic pseudocyst]. (2012) (2)
- The NOD/Shi-scid/IL-2Rγnull mice xenograft model recapitulates anaplastic large cell lymphoma dissemination to the bladder (2015) (2)
- Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with non-metastatic prostate cancer. (2018) (2)
- [A multi-institutional questionnaire survey on surgical treatment for a small renal mass: factors related with decision-making in indications for partial nephrectomy]. (2012) (2)
- Arteriovenous fistula after robot‐assisted laparoscopic prostatectomy: A rare case report (2019) (2)
- [Primary transitional carcinoma of the remaining ureter after nephrectomy for pyonephrosis: a case report]. (2005) (2)
- A narrative review of urinary phospholipids: from biochemical aspect towards clinical application (2021) (2)
- Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma. (2021) (2)
- Transition Behavior in the Use of Complementary and Alternative Medicine during Follow-up after Radical Prostatectomy: A Multicenter Survey in Japan (2010) (2)
- [A case of elderly donor in living kidney transplant after radical radiotherapy for prostate cancer]. (2009) (2)
- Large Retroperitoneal Mass Diagnosed as Adrenal Chronic Expanding Hematoma. (2015) (2)
- [Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development]. (2000) (2)
- Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens‐like epithelium (2020) (2)
- Association of ABCG2 polymorphisms with exposure and toxicity of sunitinib in a patient with renal cell carcinoma. (2010) (2)
- [Progression from adenocarcinoma to small cell carcinoma of the prostate during endocrinotherapy: a case report]. (2001) (2)
- Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening (2007) (2)
- Average shapes of uroflow curves of adult men (2009) (2)
- Assessment of lower urinary tract symptoms after Bacille Calmette-Guérin instillation therapy for non muscle-invasive bladder cancer (2012) (2)
- [A case of adenocarcinoma arising in female urethral diverticulum]. (2002) (2)
- [IgG4-related tubulointerstitial nephritis presented with multiple renal nodular lesions]. (2011) (2)
- [Right ectopic ureter with ipsilateral renal agenesis presenting with infertility: a case report]. (2004) (2)
- [A case of schwannoma in the renal hilum]. (2004) (2)
- Evaluation of prognostic factors after radical prostatectomy in pT3b prostate cancer patients in Japanese population. (2015) (2)
- [Molecular epidemiology and cancer prevention]. (2001) (2)
- [A case of urolithiasis due to vitamin D intoxication in a patient with idiopathic hypoparathyroidism]. (2002) (2)
- Novel constant‐pressure irrigation technique for the treatment of renal pelvic tumors after ipsilateral ureterectomy (2014) (1)
- [Development of a preoperative criterion to select candidates for nerve-sparing radical prostatectomy at Kyoto University Hospital]. (2014) (1)
- 486 RALGAP α2, THE INACTIVATOR OF RAL SMALL GTPASE, IS A METASTASIS SUPPRESSOR OF BLADDER CANCER (2011) (1)
- [Long-term clinical results of 5 cases of urachal carcinoma]. (2000) (1)
- Exploring optimal sequence of abiraterone and enzalutamide in patients with castration-resistant prostate cancer: The Kyoto-Baltimore collaboration. (2017) (1)
- Role of IL 13 RA 2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (2018) (1)
- [Epididymal sperm aspiration for obstructive azoospermia]. (2000) (1)
- Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort (2014) (1)
- Hormone Therapy and Castration Resistance of Prostate Cancer (2018) (1)
- Clinical characteristics of renal transplant recipients who developed de novo donor-specific antigen in Kyoto University Hospital: a case series (2022) (1)
- [Prognostic factors of prostatic cancer]. (1995) (1)
- [Nocturia and the circadian rhythm]. (2013) (1)
- 801 The impact of ureteral ligation on clinical outcome during radical nephroureterectomy for upper urinary tract urothelial carcinoma: Multi-institutional case series study JCOG1110A (2016) (1)
- Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of Hi 9 in (2016) (1)
- [Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long-Term Follow-Up]. (2018) (1)
- Long‐term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate‐targeted treatment and metastasis‐directed therapy (2021) (1)
- Renal Cell Carcinoma Common Regions of Deletion on Chromosomes 5 q , 6 q , and 10 q Updated (2006) (1)
- Carcinoma Cells by Adriamycin Enhancement of Fas-mediated Apoptosis in Renal Cell (2000) (1)
- Obstructive azoospermia as an unusual complication associated with herniorrhaphy of an omphalocele: a case report (2011) (1)
- Laparoscopic excision of an acquired ureteral diverticulum: A case report (2018) (1)
- Abstract 2813: EP4 antagonist suppresses bone metastasis in prostate cancer. (2013) (1)
- High Dose Local Irradiation to T3-4N0M0 Prostate Cancer with Intensity-modulated Radiotherapy Combined with Neoadjuvant Hormonal Therapy (2009) (1)
- Insulin-like Growth Factor-binding Protein-3 Gene-202 A / C Polymorphism Is Correlated with Advanced Disease Status in Prostate Cancer 1 (2003) (1)
- Retroperitoneal chylocoele following laparoscopic adrenalectomy: A case report (1996) (1)
- [Subclassification of the D'Amico's high risk group to predict biochemical recurrence after radical prostatectomy]. (2012) (1)
- [A case report of a young patient with invasive bladder cancer]. (2003) (1)
- The Current Status and Challenges in Augmented-Reality Navigation System for Robot-Assisted Laparoscopic Partial Nephrectomy (2020) (1)
- 66: Subtyping of Uropathogenic Escherichia Coli According to Genetic Mosaicism in the Pathogenicity Island Encoding USP Protein (2005) (1)
- [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment]. (2005) (1)
- Systematic chemical screening identifies disulfiram as a repositionable drug that enhances sensitivity to cisplatin in bladder cancer: A summary of preclinical studies (2019) (1)
- Prospective evaluation of a "Watchful Waiting" program using initial pathology criteria and PSA-doubling time monitoring for patients with stage T1c prostate cancer. (2006) (1)
- Comparative analysis of perioperative outcomes between robot-assisted partial nephrectomy and open partial nephrectomy: a propensity-matched study (2021) (1)
- Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database. (2012) (1)
- [Initial Clinical Experience of Nivolumab for Metastatic Renal Cell Carcinoma]. (2018) (1)
- Population-Based Survey of Overactive Bladder in Japan: A Cross-Sectional Analysis of the Nagahama study (2016) (1)
- [BK virus nephropathy in a kidney transplant recipient: a case report and literature review]. (2006) (1)
- Oxygen Species Cisplatin through the Accumulation of Intracellular Reactive Sensitizing Effect of Galectin-7 in Urothelial Cancer to Updated (2007) (1)
- Protocol for development and validation of a prediction model for 5-year risk of incident overactive bladder in the general population: the Nagahama study (2021) (1)
- Bladder urothelial carcinoma producing insulin‐like growth factor II: A case report (2018) (1)
- Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients (2021) (1)
- Multicenter randomized controlled trial of life style measures alone versus life style measures plus ramelteon for nocturia: an interim analysis (2014) (1)
- ESTABLISHMENT OF NOVEL MOUSE BLADDER CANCER CELL LINES MIMICKING INTRINSIC SUBTYPE OF HUMAN INVASIVE BLADDER CANCER: MP88‐20 (2017) (1)
- [A study on parameters to predict tumor volume for stage T1c prostate cancers of Gleason score 6 or less]. (2000) (1)
- Phase II open-label study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced or metastatic urothelial carcinoma. (2021) (1)
- 144 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES MULTIPLE NEW SUSCEPTIBILITY LOCI FOR PROSTATE CANCER IN JAPANESE POPULATION (2011) (1)
- Prostate‐specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study) (2021) (1)
- [A case of prostate carcinosarcoma successfully treated with combined modality therapy]. (2013) (1)
- Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up (2021) (1)
- 1149 FLUORESCENT IMAGING OF HIGH GRADE BLADDER CANCER USING A SPECIFIC ANTAGONIST FOR CHEMOKINE RECEPTOR CXCR4 (2010) (1)
- A 45,X/46,XY Male with Orchidopexy Diagnosed with Mixed Germ Cell Tumor After 21-year Follow-up (2017) (1)
- Thymic cancer mimicking a metastasis of testicular seminoma (2015) (1)
- Re: Office based flexible cystoscopy may be less painful for men allowed to view the procedure. A. R. Patel, J. S. Jones, S. Angie and D. Babineau J Urol 2007; 177: 1843-1845. (2007) (1)
- Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab (2022) (1)
- Over expression of thioredoxin-1 in transgenic mice attenuates germ cell apoptosis induced by experimental cryptorchidism. (2004) (1)
- 775: Cell Culture Proteome Identifies CXCL 1 as a Secreted Marker and Mediator for the Tumor Invasion of Bladder Cancer (2007) (1)
- Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy (2022) (1)
- Interim Outcomes of a High-dose Whole Pelvic IMRT for Very High-risk Group of Patients With Locally Advanced Prostate Cancer (2012) (1)
- Living related renal transplantation for end‐stage renal disease after liver transplantation from a brain‐dead donor (2003) (1)
- Non-drug lifestyle measures for the management of nocturia (2007) (1)
- [Genetic analysis in prostate cancer]. (2014) (1)
- [A Case of Rapidly Progressive Metastatic Castration-Resistant Prostate Cancer : Durable Control by Early Induction of Carboplatin and Paclitaxel]. (2015) (1)
- [Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report]. (2014) (1)
- Solid testicular mass in a 44-year-old man. (2013) (1)
- [Post-Operative Urethral Stricture after Holmium Laser Enucleation of the Prostate]. (2019) (1)
- Abstract 300: Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation (2010) (1)
- [A case of retroperitoneal dedifferentiated liposarcoma initially diagnosed as malignant fibrous histiocytoma: a case report]. (2006) (1)
- [Questionnaire survey on the theory of antimicrobial prophylaxis in urologic surgery]. (2004) (1)
- [A case of amyloidosis of the ureter caused by primary macroglobulinemia]. (2011) (1)
- 255: Prognostic Prediction of Metastatic Prostate Cancer Using Genetic Polymorphisms (2005) (1)
- [A case of malignant lymphoma with bilateral adrenal involvement]. (2003) (1)
- Comparison of the Effects by Obybutynin and Tolterodine on Spina Bifida Patients: A Pilot Crossover Study (2011) (1)
- Asia-1 Perspective role of the Urological Association of Asia (UAA) in the next decade(Future of Urology in Asia) (2011) (0)
- Abstract 5046: High-throughput chemical screening for sensitization of bladder cancer to gemcitabine and cisplatin chemotherapy (2016) (0)
- Evaluation of the Degree of Heat Conduction with the da Vinci Surgical System (2019) (0)
- Survival outcomes of neoadjuvant hormone therapy plus external-beam radiotherapy with relatively early initiation of salvage hormone therapy to patients with T3-4N0M0 prostate cancer. (2011) (0)
- MP24-15 CLINICAL UTILITY OF DETECTING LOW-FREQUENCY CELL-FREE DNA VARIANTS IN CASTRATION-RESISTANT PROSTATE CANCER (2021) (0)
- 375 Clock gene Rev-erbβ competes with Rev-erbα for transactivation of the connexin43 gene expression, coding a gap-junction protein in urinary bladder (2014) (0)
- [A case of membranous glomerulonephritis in renal allograft]. (2002) (0)
- Expression of PTHrP and PTH/PTHrP receptor 1 (PTH1R) in normal and diseased bladder detrusor muscle. (2013) (0)
- [Xanthogranulomatous pyelonephritis presenting a subcutaneous mass in the lower abdomen: a case report]. (2006) (0)
- 434 Four loci at 11q12, 10q26, 3p11.2, and 2p11 are associated with prostate cancer susceptibility in the Japanese population (2012) (0)
- Involvement of SDF-1 in recruitment of alpha smooth muscle actin-positive cells to the urinary bladder. (2011) (0)
- Laparoscopic Forceps with Force Feedback (2018) (0)
- 155: Clinical Implication of Vascular Endothelial Growth Factor (VEGF) T-460c Polymorphism in the Risk and Progression of Prostate Cancer (2007) (0)
- Sequential Therapy with Docetaxel and Cabazitaxel Starting at Low PSA Levels was Associated with Longer Survival in Patients with Castration-Resistant Prostate Cancer (2021) (0)
- MP60-02 SINGLE NUCLEOTIDE POLYMORPHISMS IN SLC45A3 AND KLK3 ARE CORRELATED WITH SERUM PSA LEVELS AND ARE POTENTIAL BIOMARKERS FOR DETECTING PROSTATE CANCER (2015) (0)
- 424: Androgen Dependent Activation of Protein Kinase Cζ and its Roles of Androgen-Independent Cell Proliferation in Prostate Cancer Cells (2006) (0)
- [Clinical results of immunosuppressive triple therapies in living-related renal transplantation--a single center experience]. (2004) (0)
- Gap junction regulates detrusor activity in bladder inflammation. (2016) (0)
- QUANTITATIVE ANALYSIS OF VEGF, VEGF-C AND VEGFR-2 GENE EXPRESSION IN RENAL CELL CARCINOMA (1999) (0)
- Enzalutamide plus androgen deprivation therapy (ADT) versus flutamide plus ADT in men with castration-resistant prostate cancer (CRPC): AFTERCAB. (2021) (0)
- A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study (2019) (0)
- MP57-08 PROSTATE-SPECIFIC ANTIGEN DENSITY IS THE MOST APPROPRIATE FACTOR FOR DETECTING UNFAVORABLE PATHOLOGY AFTER RADICAL PROSTATECTOMY IN MEN ELIGIBLE FOR ACTIVE SURVEILLANCE FROM MUTLI-INSTITUTIONAL STUDY (2016) (0)
- The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients (2019) (0)
- Molecular genetic analysis of human renal tumors by using restriction fragment length polymorphisms (1994) (0)
- MP2-19 SUBSTRATIFICATION OF D'AMICO HIGH RISK PROSTATE CANCER REVEALS CLINICALLY DISTINCT POPULATIONS: AN AMERICAN VALIDATION OF THE JAPANESE MODEL (2014) (0)
- COMPARATIVE ANALYSIS OF POST-TREATMENT BIOCHEMICAL OUTCOMES OF LOCALISED PROSTATE CANCER IN A JAPANESE POPULATION: WHAT IS THE BEST APPROACH FOR HIGH-RISK PATIENTS? (2006) (0)
- Erratum to: Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma. (2018) (0)
- Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report. (2002) (0)
- MP41-01 IMPACT OF HISTOLOGICAL VARIANTS ON CLINICAL OUTCOMES IN PATIENTS WITH CHEMORESISTANT UROTHELIAL CANCER TREATED WITH PEMBROLIZUMAB: A PROPENSITY SCORE MATCHING ANALYSIS (2021) (0)
- Is Adjuvant Hormonal Therapy Necessary to Japanese Patients with Locally Advanced Prostate Cancer Treated by 3D-CRT? (2008) (0)
- Title Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy (2019) (0)
- Oncogenes in Renal Cell Carcinoma (1995) (0)
- [A case of accelerated acute rejection in kidney transplantation rescued by plasma exchange]. (2005) (0)
- PURINE-RICH ELEMENT BINDING PROTEIN ALPHA INDUCES CELL STRESS AND DIFFERENTIATION PATHWAYS IN PROSTATE CANCER CELLS (2009) (0)
- 511 INCIDENCE OF BLADDER CANCER AFTER CURATIVE RADIATION THERAPY VERSUS RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER (2012) (0)
- 3D-CRT and IMRT for prostate cancer (2005) (0)
- [A Case of Primary Ewing Sarcoma of the Kidney Treated with Multidisciplinary Approach]. (2020) (0)
- 204 NARDILYSIN IS ASSOCIATED WITH PROSTATE CANCER AGGRESSIVENESS AND IS A POTENTIAL TISSUE AND SERUM MARKER (2013) (0)
- [Cross-sectional survey of voiding habits in male patients undergoing ileal neobladder reconstruction]. (2009) (0)
- 110 The expression profile of phosphatidylinositol in high resolution imaging mass spectrometry is a potential biomarker for prostate cancer (2014) (0)
- 395: Expression Analysis of NDRG1, An Androgen-Induced, Stress Responsive Gene, in Prostate Cancer (2005) (0)
- 66 Parathyroid hormone related peptide is endogenous relaxant of spontaneous detrusor smooth muscle contraction (2013) (0)
- 468: Polymorphic CA Repeats in IGF-I Gene is a Common Genetic Modifier in the Etiology of Prostate Cancer and Benign Prostatic Hyperplasia (2004) (0)
- EP-1309: Long-term outcome of IMRT with neoadjuvant hormonal therapy under early salvage policy for T3-4N0M0 prostate cancer (2014) (0)
- MP09-16 IDENTIFICATION OF IL13RA2 AS A BIOMARKER FOR PREDICTING CASTRATION-RESISTANCE OF PROSTATE CANCER USING PATIENT DERIVED XENOGRAFT MODELS (2020) (0)
- [Experience of transobturator sling for iatrogenic male stress urinary incontinence]. (2013) (0)
- [Multi-institute survey on actual conditions of urologic management for severe bladder dysfunction after hysterectomy]. (2008) (0)
- PD44-01 NOT A STRAIGHTFORWARD RELATION BETWEEN ESTIMATED DAILY SODIUM INTAKE AND NOCTURIA: THE NAGAHAMA STUDY (2020) (0)
- Basic fibroblast growth factor (bFGF) could be a key regulator for myogenic bladder overactivity through gap junction generation in the smooth muscle. (2010) (0)
- smooth muscle overactivity through gap junction generation in the Basic fibroblast growth factor causes urinary bladder (2016) (0)
- MP-16.14 Improved Grouping System Combining Gleason Score for Group IV of TNM Prognostic Grouping for Prostate Cancer: Results from J-CAP Database (2011) (0)
- Outcomes of high-dose whole pelvic simultaneous integrated boost IMRT in patients with pelvic lymph node-positive prostate cancer. (2019) (0)
- Prediction of survival in patients with metastatic prostate cancer by single nucleotide polymorphisms of cancer-associated genes. (2012) (0)
- 1A1-F07 Development of Low-Cost Soft Organ Model with Virtual Tumors (2015) (0)
- External-beam radiotherapy combined with neoadjuvant hormonal therapy (2007) (0)
- p2PSA-associated parameters are significant predictors of reclassification of first-year protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study. (2021) (0)
- Abstract 4677: Non-prostate cancer death within 5 years after radical therapy in men with localized prostate cancer. (2013) (0)
- Successful surgical management of recurrent urachal adenocarcinoma: A case report (2020) (0)
- STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma (2022) (0)
- Absence of Association between E-Cadherin Gene Polymorphism at Position-160 in Promoter Region and Risk of Urothelial Cancer (2003) (0)
- Reply by Authors. (2019) (0)
- Subjective and objective assessment of efficacy and tolerability of mirabegron, a ß(3)-adrenoceptor agonist, in clinical use (2013) (0)
- BALB/C-FCGR2B-/-PDCD-/- MOUSE EXPRESSING ANTI-UROTHELIAL ANTIBODY IS A MODEL OF AUTOIMMUNE CYSTITIS (2009) (0)
- 1583: PSA-Doubling Time Assessment Based Upon 4 Consecutive Measurements for 6 Months: Is it a Realistic Strategy to Spare Over-Treatment for Patients with Stage T1C Prostate Cancer Presenting Favorable Biopsy Features? (2006) (0)
- 644: Impact of Galectin 7 Expression on the Chemosensitivity of Urothelial Cancer (2006) (0)
- PD23-04 THE POTENTIAL UTILITY OF CHEMOKINE CXCL1 (GROα) AS A NOVEL DIAGNOSTIC AND PROGNOSTIC MARKER FOR BLADDER CANCER (2015) (0)
- POS-02.09: Triptolide (PG490)-mediated sensitization of urothelial cancer cells to cisplatin via the interaction between glycogen synthase kinase-3β and p53 (2007) (0)
- 202 Discovery of urinary biomarker candidates for prostate cancer based on proteomic analyses (2014) (0)
- 535 The obesity paradox in nocturia? Lower body mass index is a risk factor of mortality in outpatients with nocturia in Japan (2016) (0)
- A modified bioinformatics approach of detecting low-frequency mutations in cell-free DNA to achieve precision medicine for advanced prostate cancer (2019) (0)
- [Laminectomy for spinal cord compression occurring in hormone refractory prostate cancer]. (2002) (0)
- Allelic Imbalances on Chromosome 20 in Human Transitional Cell Carcinoma (2000) (0)
- CIRCADIAN RHYTHM COORDINATES ATP RELEASE IN THE UROTHELIUM VIA CONNEXIN43 HEMICHANNELS.: PD70‐11 (2017) (0)
- 322 RISK ESTIMATION MODEL WITH MULTIPLE COMMON GENETIC VARIANTS FOR JAPANESE PROSTATE CANCER (2012) (0)
- The effects of Gosha-Jinki-Gan, a blended herbal medicine, and furosemide for nocturnal polyuria with elevated B-type natriuretic peptide: a crossover trial. (2010) (0)
- ENDOTHELIAL FENESTRATION OF TUMOUR MICROVASCULATURE AS A PREDICTIVE FACTOR OF ANTI-VEGF THERAPY IN CLEAR CELL RENAL CELL CARCINOMA (2008) (0)
- Japanese Population Prostate Cancer and Benign Prostatic Hyperplasia in a Gene Polymorphism with Vitamin D Receptor Association of Updated Version (2000) (0)
- RHEB, A NOVEL SMALL G-PROTEIN OF RAS SUPERFAMILY, IS ASSOCIATED WITH PROLIFERATION IN HUMAN PROSTATE CANCER CELL LINES (2006) (0)
- Relaxation of IGF2/H19 imprinting in Wilms tumour is associated with a switch in DNA methylation (1994) (0)
- Correlates of nocturnal voiding in women: cardiovascular and metabolic factors (2011) (0)
- Association of Vitamin D Receptor Gene Polymorphism with Prostate Cancer and Benign Prostatic Hyperplasia in a Japanese Population 1 (2000) (0)
- Patient-Derived Urothelial Cancer Xenograft Models: A Systematic Review and Future Perspectives (2020) (0)
- 1085 Adverse event profiles of alpha-1 blocker agents for male patients: Data mining of the public version of the FDA adverse event reporting system (2013) (0)
- 170 Identification of novel microRNAs associated with epithelial-mesenchymal transition in human bladder cancer by miRNA chip array profiling (2012) (0)
- [A case of small cell carcinoma of the ureter]. (2008) (0)
- The development of a 3D navigation system for robot-assisted partial nephrectomy using augmented reality technology (2019) (0)
- Influence of Cigarette Smoking and Schistosomiasis on p53 Gene Mutation in Urothelial Cancer1 (2006) (0)
- MP09-18 MISSENSE POLYMORPHISM IN SRD5A2 IN COMBINATION WITH HSD3B1 VARIATION IS ASSOCIATED WITH OUTCOME OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH ABIRATERONE (2020) (0)
- MP-16.15: Endothelial fenestration of tumor microvasculature as a predictive factor of anti-VEGF therapy in clear cell renal cell carcinoma (2007) (0)
- A Pilot Study of Hypofractionated Intensity Modulated Radiation Therapy Over 3 Weeks for Localized Prostate Cancer (2016) (0)
- Abstract 1575: ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation (2014) (0)
- 1102 Guideline adherence of immediate post-TUR intravesical chemotherapy for patients with non-muscle invasive bladder cancer (2014) (0)
- [Deceased Donor Kidney Transplantation from a Liver Transplantation Recipient]. (2016) (0)
- Development and validation of prediction model for incident overactive bladder: The Nagahama study (2022) (0)
- MP5-03 ADHERENCE AND ADEQUACY OF THE BLADDER CANCER GUIDELINES FOR POST-TUR FOLLOW-UP INTERVAL (2015) (0)
- ANDROGEN-DEPENDENT REGULATION OF PROTEIN KINASE Cζ AND ITS ROLES FOR PROGRESSION TO ANDROGEN INDEPENDENCY IN PROSTATE CANCER CELLS (2008) (0)
- Title A 45,X/46,XY Male with Orchidopexy Diagnosed with Mixed Germ Cell Tumor After 21-year Follow-up (2018) (0)
- Title Up-regulation of miR-582-5 p regulates cellular proliferation ofprostate cancer cells under androgen-deprived conditions (2019) (0)
- 7030 POSTER Outcomes of Intensity-Modulated Radiation Therapy Combined With Neoadjuvant Hormonal Therapy for High-risk Prostate Cancer (2011) (0)
- MP03-07 IMPACT OF PRIOR INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER ON THE EFFICACY OF PEMBROLIZUMAB IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA (2022) (0)
- HIGH‐THROUGHPUT CHEMICAL SCREENING FOR SENSITIZATION OF BLADDER CANCER TO GEMCITABINE AND CISPLATIN CHEMOTHERAPY: MP44‐19 (2017) (0)
- MP03-15 LAPAROSCOPIC ADRENALECTOMY FOR METASTATIC TUMORS IS FEASIBLE FOR SELECTED PATIENTS: RETROSPECTIVE MULTICENTER STUDY IN JAPANESE POPULATIONS (2018) (0)
- [Significance of chromosome 9 alterations as an initial step in urothelial carcinogenesis]. (2000) (0)
- [A Case of Pelvic Unicentric Castleman Disease Treated by Preoperative Transcatheter Arterial Embolization and Tumor Complete Resection with Combined Lower Abdominal and Posterior Approach]. (2021) (0)
- MP16-17 GENOMIC LANDSCAPE OF METASTATIC HORMONE- NAÏVE PROSTATE CANCER (2020) (0)
- 2052 INSULIN-LIKE GROWTH FACTOR-I (IGF-I) POLYMORPHISMS PREDICT THE SURVIVAL OF PROSTATE CANCER PATIENTS WITH BONE METASTASIS AT INITIAL PRESENTATION (2010) (0)
- Tumor targeting of gene expression through metal-coordinated conjugation with dextran [J. Control. Release (2003) 88 297-312]. (2016) (0)
- [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer]. (1999) (0)
- INFLUENCE OF POLYMORPHISMS AND EXPRESSION OF CHROMOGRANIN A AND ENDOTHELIN-1 ON THE DEVELOPMENT AND PROGRESSION OF PROSTATE CANCER (2009) (0)
- 738: Low-Level Expression of EphA2 is Associated with P53 Mutations and Intravesical Recurrence in Bladder Cancer (2004) (0)
- Association of sunitinib pharmacokinetics with toxicity and genetic polymorphism in efflux transporter ABCG2 in patients with renal cell carcinoma. (2011) (0)
- MP35-13 IL13RA2 MEDIATES RESISTANCE TO SUNITINIB IN PRIMARY XENOGRAFT MODELS OF CLEAR CELL RENAL CELL CARCINOMA (2014) (0)
- Prediction of survival in patients with metastatic prostate cancer by single nucleotide polymorphisms of cancer-associated genes. (2012) (0)
- Retraction Note: In Vitro Transfection of Plasmid DNA by Amine Derivatives of Gelatin Accompanied with Ultrasound Irradiation (2020) (0)
- Grand Rounds Solid Testicular Mass in a 44-Year-Old Man (2013) (0)
- Symposium Organizers (2018) (0)
- Regional distribution of lymph node metastasis in upper urinary tract urothelial cancer, sub-analysis of large multi-institutional study (JCOG1110A) (2018) (0)
- 99mTc-mercaptoacetyltriglycine Cortical Renography Predicts Outcomes in Adult Living Donor Renal Transplant Recipients. (2020) (0)
- 2234 A COMMON GENETIC VARIANTS BASED RISK PREDICTION MODEL FOR PROSTATE CANCER IS HIGHLY REPRODUCIBLE IN JAPANESE, AND COMPENSATES FOR PROSTATE SPECIFIC ANTIGEN AT GRAY-ZONE (2013) (0)
- [A case of growing teratoma syndrome; long-term control accomplished by systemic interferon therapy with adequate local therapies]. (2015) (0)
- UP-2.069: Upregulation of JunB by the Inactivation of Von Hippel-Lindau Tumor Suppressor Protein Induces Angiogenesis and Promotes Tumor Growth Via MMP-2 Upregulation (2009) (0)
- [A case report: recurrence of urothelial cancer in an ileal conduit]. (2009) (0)
- Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1 (2022) (0)
- [Presurgical treatment of axitinib reduced operation risk by downsizing the vena cava tumor thrombus in advanced renal cell carcinomas: two case reports]. (2014) (0)
- Predictors of the efficacy of non-drug lifestyle modifications for the management of nocturia (2009) (0)
- [A case of late perirenal fat recurrence after partial nephrectomy for T1A renal cell carcinoma]. (2014) (0)
- 426: Basic Fibroblast Growth Factor (BFGF) Promotes Bladder Smooth Muscle Cell Proliferation and Matrix Remodeling through ERK1/2 Pathway (2007) (0)
- 446: Hypoxia Inducible Factor-Independent Function of PVHL and Its Roles on the Development of Familial Pheochromocytoma (2007) (0)
- 138 Exploring a novel therapeutic target for neuroendocrine prostate cancer using a xenograft model of trans-differentiation (2016) (0)
- DISTRIBUTION OF LYMPH NODE METASTASIS IN UPPER URINARY TRACT UROTHELIAL CANCER, SUB‐ANALYSIS OF JCOG1110A STUDY: MP71‐18 (2017) (0)
- [A case of renal cell carcinoma associated with paraganglioma]. (2011) (0)
- Safe and effective administration of BCG for bladder carcinoma in situ after umbilical cord blood stem cell transplantation (2017) (0)
- [The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort]. (2019) (0)
- [Two-stage nephron-sparing surgery for bilateral T2 renal cell carcinoma and von Hippel-Lindau disease: a case report]. (2009) (0)
- Phase I clinical study of cabazitaxel plus prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in a Japanese population. (2014) (0)
- MP41-08 AMINO-TERMINAL ENHANCER OF SPLIT/AES IS A TUMOR AND METASTASIS SUPPRESSOR OF PROSTATE CANCER (2014) (0)
- [Urologic laparoscopy]. (2000) (0)
- MP35-15 DEVELOPMENT AND VALIDATION OF A NOVEL PROGNOSTIC MODEL FOR PREDICTING OVERALL SURVIVAL IN TREATMENT NAIVE CASTRATION-SENSITIVE METASTATIC PROSTATE CANCER. (2018) (0)
- EP-1125 OUTCOMES OF HIGH DOSE DYNAMIC CONFORMAL ARC IRRADIATION FOR PATIENTS WITH T1C-T2N0M0 PROSTATE CANCER (2012) (0)
- Dynamic Roles of GTP Metabolism in Cancers—Challenge for a New, Selective and Safe Approach to Eradicate Cancers (2016) (0)
- Barriers for sperm cryopreservation in advanced germ cell tumor patients: a 20-year experience (2020) (0)
- Masked acute rejection of the graft kidney under the recovery of native kidneys in a patient who underwent simultaneous liver and kidney transplantation (2020) (0)
- 75 STAT3 polymorphism can predict clinical benefits of interferon-α in patients with metastatic renal cell carcinoma (2012) (0)
- The role of adjuvant chemotherapy for pT2-4 upper urinary tract urothelial cancer: Exploratory analysis of large multi-institutional study (JCOG1110A). (2019) (0)
- [Transitional cell carcinoma in prostate after intravesical instillation of Bacillus Calmette-Guerin]. (2004) (0)
- 287 Amino-terminal enhancer of split/AES is a tumor and metastasis suppressor of prostate cancer (2015) (0)
- MP-15.09: Functional Analysis of a Novel Soft Tissue Sarcoma Metastasis-Associated Molecule in Prostate Cancer (2009) (0)
- Abstract 1920: Variation of ERG oncoprotein expression in prostate cancer patients with different ethnicities. (2013) (0)
- VITAMIN D RECEPTOR GENE POLYMORPHISMS AS A GENETIC MARKER FOR PROSTATE CANCER PREDISPOSITION (1999) (0)
- An analysis of STAT3 polymorphism on outcomes of interferon-alpha treatment in patients with metastatic renal cell carcinoma. (2011) (0)
- MECHANISMS OF ACQUIRING ANDROGEN-INDEPENDENCE IN NOVEL PROSTATE CANCER XENOGRAFT MODEL (2008) (0)
- Nocturia versus Insomnia or Sleep Apnea Syndrome: Comparisons of Patient Characteristics in Outpatient Clinics (2010) (0)
- Mortality of outpatients with nocturia is not higher than that of the Japanese population (2013) (0)
- 2287 PREDICTION OF SURVIVAL IN METASTATIC PROSTATE CANCER PATIENTS BY SNP ARRAY ANALYSIS OF CANCER-ASSOCIATED GENES (2011) (0)
- [Socioeconomic advantages of longer screening intervals for men with low prostate-specific antigen levels in prostate cancer mass screening]. (2013) (0)
- MP-17.12: Bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient (2006) (0)
- Use of STAT3 polymorphisms to predict overall survival in patients treated with interferon-alpha for metastatic renal cell carcinoma. (2012) (0)
- 839 RalGAP, the inactivator of Ral small GTPase, suppresses the progression of prostate cancer (2012) (0)
- ENDOTHELIAL FENESTRATIONS IN TUMOR MICROVASCULATURE AS A POTENT PREDICTIVE MARKER OF ANTI-VEGF THERAPY IN CLEAR CELL RENAL CELL CARCINOMA (2009) (0)
- [Diagnosis and treatment of prostate cancer--it's diversity and future prospects]. (2001) (0)
- 607 A FUNCTIONAL VARIANT IN NKX3.1 ASSOCIATED WITH PROSTATE CANCER SUSCEPTIBILITY DOWN-REGULATES NKX3.1 EXPRESSION (2011) (0)
- in Prostate Cancer Polymorphism Is Correlated with Advanced Disease Status C / A Insulin-like Growth Factor-binding Protein-3 Gene-202 Updated (2003) (0)
- INTRAVESICAL PROSTATIC PROTRUSION IS NOT THE SAME IN ITS SHAPE: EVALUATION BY PREOPERATIVE CYSTOSCOPY AND OUTCOME IN HOLEP: MP02‐12 (2017) (0)
- Title Late recurrence of nonseminomatous germ cell tumor successfully treated with intensity-modulated radiation therapy (2018) (0)
- Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database. (2012) (0)
- MP49-14 PREDICTIVE VALUE OF RADIOLOGICAL RESPONSE RATE FOR PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND POST-CYSTECTOMY SURVIVAL OF BLADDER UROTHELIAL CANCER (2016) (0)
- Constitutional relaxation of insulin-like growth factor II gene implicated in Wilms' tomor (1993) (0)
- 549 Prediction of survival in metastatic prostate cancer patients by single nucleotide polymorphisms of cancer-associated genes (2012) (0)
- Enhanced expression of plasmid dna - cationized gelatin complex by ultrasound in murine muscle [J. Control. Release 80 (2002) 345-356]. (2016) (0)
- FP281POST-TRANSLATIONAL MODIFICATION OF MRP8 (S100A8) AND ITS ROLE IN CHRONIC KIDNEY DISEASE (2018) (0)
- [Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens]. (1999) (0)
- [A Case of Advanced Right Renal Pelvic Cancer with Left Supraclavicular Lymph Node Metastasis that Attained Long-Term Survival by Multidisciplinary Treatments]. (2019) (0)
- [Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report]. (2021) (0)
- 258 DEVELOPMENTAL ANALYSIS OF MICTURITION IN INFANT MOUSE IMMEDIATELY AFTER WEANING MEASURED BY A NEW RECORDING SYSTEM, AUTOMATED VOIDED STAIN ON PAPER (AVSOP) METHOD (2011) (0)
- [Pseudohypoaldosteronism type 1 in an infant with bilateral primary obstructive megaureter : a case report]. (2011) (0)
- [Kidney Auto-Transplantation for Intraoperative Right Renal Artery Injury in a Single Kidney Patient : A Case Report]. (2019) (0)
- Dynamic role of GTP-energy metabolism in metastasis of renal cell carcinomas: Prognosis and therapeutic applications. (2016) (0)
- MP-20.01: Fluorescent Imaging of Bladder Cancer Using T140 Analogue, A CXCR4 Antagonistic Peptide (2009) (0)
- [Promotion of Diversity in the Academic Field of Urology : Analysis of 10,000 Articles Published in Acta Urologica Japonica during a 65-Year Period]. (2021) (0)
- PD50-08 INSOMNIA INDUCES LOWER URINARY TRACT SYMPTOMS: THE NATURAL HISTORY AND RISK FACTORS FOR LUTS FROM THE NAGAHAMA LONGITUDINAL STUDY (2018) (0)
- 677 IDENTIFICATION OF EP4 AS A POTENTIAL TARGET FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER USING A NOVEL XENOGRAFT MODEL (2010) (0)
- PD49-06 EXTRACELLULAR VESICLES SECRETED BY BONE TROPIC RENAL CELL CARCINOMA INDUCE ANGIOGENESIS IN BONE MARROW WITH POTENTIAL TO FACILITATE BONE METASTASIS (2021) (0)
- PD49-10 EFFECT OF CYTOTOXIC T LYMPHOCYTE REGENERATED FROM IPS CELLS IN PRECLINICAL MODELS OF RENAL CELL CARCINOMA (2021) (0)
- [Clinical Effect of Nivolumab on Advanced Renal Cell Carcinoma with Peritoneal Metastasis]. (2019) (0)
- 669 A phase III, multicenter, randomized, controlled study of maximum androgen blockade with vs without zoledronic acid in prostate cancer patients with metastatic bone disease: Results of main secondary endpoints in ZAPCA trial (2015) (0)
- Title Expression of parathyroid hormone / parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles : A clinico-pathological study (2018) (0)
- [A case of bladder paraganglioma managed by transurethral approach, using holmium laser]. (2010) (0)
- MP-15.03: EP4 Is a Novel Potential Target for the Treatment of Androgen-Independent Prostate Cancer (2009) (0)
- Reply by Authors. (2020) (0)
- Development of a Multiplex RNAUrine Test for the Detection and Stratification ofTransitional Cell Carcinoma of the Bladder (2008) (0)
- [Significance of PSA nadir as a tool of predicting biochemical failure after radical prostatectomy for prostate cancer]. (2011) (0)
- 615 Pathological outcomes after radical prostatectomy in men eligible for active surveillance, multi-institutional study (2016) (0)
- Gene expression Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models (2007) (0)
- PTHrP signalling system is activated by acute bladder distension (2012) (0)
- Asian School of Urology, Young Leaders' Workshop, Kyoto 2010 (2011) (0)
- [Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer]. (2002) (0)
- [Pelvic lymph node dissection in robot-assisted laparoscopic radical prostatectomy: safety and adequacy in introductory series]. (2015) (0)
- 247: The Role of F70 S6K Pathways in the Progression to Androgen Independent Cell Proliferation in Prostate Cancer Cells (2005) (0)
- [Therapeutic strategy for prostate specific antigen (PSA) failure after radical prostatectomy]. (2003) (0)
- MP28-08 INTRAVITAL TWO-PHOTON IMAGING OF BLADDER REVEALED THE ACTIVATION OF UROTHELIAL ERK BY STRETCH-INDUCED INTRAVESICAL RELEASE OF ADENOSINE TRIPHOSPHATE (2020) (0)
- Title Amino-terminal enhancer of split gene AES encodes a tumorand metastasis suppressor of prostate cancer (2019) (0)
- Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study) (2016) (0)
- [Hemorrhagic adrenocortical adenoma with myelolipoma: a case report]. (2006) (0)
- 787 ASSOCIATION OF GENETIC POLYMORPHISMS AT 8Q24 WITH THE RISK OF PROSTATE CANCER IN A JAPANESE POPULATION (2009) (0)
- PD13-11 LONGER INTERVAL BETWEEN DISEASE ONSET AND TREATMENT INITIATION IS ASSOCIATED WITH UNFAVORABLE PATHOLOGICAL AND ONCOLOGICAL OUTCOMES OF NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CANCER (2016) (0)
- 1390: GSTT1 Polymorphism is Associated with Improvement of Seminal Findings after Varicocelectomy (2004) (0)
- 1324: Gemcitabine and Paclitaxel Regimen for Patients with Advanced Transitional Cell Carcinoma (2005) (0)
- Differences and Associations between Night-time Frequency/Nocturia and Sleep Disorders (2009) (0)
- Circadian rhythms of micturition during jet lag. (2018) (0)
- 604: Immunohistochemical Analysis of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Expression in Prostate Cancer (2004) (0)
- Triptolide (PG490)-mediated sensitization of urothelial cancer cells To Cisplatin-induced apoptosis (2006) (0)
- 684 IN VITRO CULTURE OF SPERMATOGONIAL STEM CELLS FROM AZOOSPERMA PATIENTS (2011) (0)
- [Activation of imprinted genes in human carcinogenesis]. (1995) (0)
- [Salvage hormonal therapy against recurrence after curative external beam radiotherapy for locally advanced prostate cancer at Kyoto University Hospital]. (2012) (0)
- Add-on effects of tadalafil for tamsulosin-treated patients with benign prostatic hyperplasia suffering from residual lower urinary tract symptoms: a randomized, placebo-controlled, double-blind, crossover study (2019) (0)
- S14-5 Management of high risk superficial bladder cancer : the timing of radical cystectomy(Symposium 14「Management of Superficial Bladder Cancer」) (2006) (0)
- [Renal artery pseudoaneurysm following retroperitoneal laparoscopic partial nephrectomy]. (2009) (0)
- [Simultaneous Hepatorenal Transplantation from a Brain-Dead Donor for Graft Dysfunction and Renal Insufficiency in a Liver Transplant Recipient : A Case Report]. (2017) (0)
- Kit and method for detecting urothelial carcinoma (2006) (0)
- 109: Higher Biofilm Productivity in Escherichia Coli Strains Isolated from Prostatitis Patients, Compared those from Cystitis and Pyelonephritis (2004) (0)
- Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese patients. (2012) (0)
- PROSTATE CANCER LOCI WITH NEGATIVE MULTIPARAMETRIC MRI FOR PROSTATE CANCER: CORRELATION WITH PROSTATECTOMY SPECIMENS: MP20‐08 (2017) (0)
- Dietary counseling focused on sodium restriction reduces nocturnal urine volume and nocturnal polyuria index in renal allograft recipients with nocturnal polyuria (2016) (0)
- 509 UPSTREAM REGULATORS FOR ANDROGEN-DEPENDENT ACTIVATION OF ATYPICAL PROTEIN KINASE C IN PROSTATE CANCER CELLS AND THEIR ROLES FOR ANDROGEN-INDEPENDENT PROGRESSION (2009) (0)
- [Urinary diversion in patients treated with pelvic irradiation: transverse colon conduit revisited]. (2014) (0)
- Retroperitoneoscopic nephrectomy for polycystic kidney disease (2007) (0)
- OF SERUM p 53 ANTIBODIES IN PATIENTS WITH UPPER URINARY TRACT TUMORS (2005) (0)
- Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN (2021) (0)
- 1761 CLINICAL CHARACTERISTICS OF XP11.2 TRANSLOCATION RENAL CELL CARCINOMA IN ADULT JAPANESE PATIENTS (2011) (0)
- Left renal mass presenting uncommon pattern of extension in a patient with intestinal malrotation (2017) (0)
- Importance of performance status, corrected calcium, and microvascular invasion in predicting overall survival in patients with metastatic renal cell carcinoma at the era of molecular targeted therapy. (2013) (0)
- [Clinical Utility of Upper Urinary Tract Reconstruction by Ileal-Ureter Substitution]. (2018) (0)
- Pilot study of moderately-hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer. (2018) (0)
- MP26-16 PERFORMANCE OF PROMPT-PROSTATE GENETIC SCORE IN A JAPANESE COHORT (2021) (0)
- IDENTIFICATION OF NINE NEW SUSCEPTIBILITY LOCI FOR PROSTATE CANCER IN THE JAPANESE POPULATION: MP70‐09 (2018) (0)
- Preoperative nomogram for predicting locally advanced disease in patients with upper urinary tract urothelial carcinoma (2018) (0)
- [Recent advancements in prostate cancer basic research]. (2016) (0)
- Re: Impact of Nocturia on Mortality: The Nagahama Study. (2020) (0)
- [A case of successful living related renal transplantation in a patient with end-stage renal disease resulting from sarcoidosis]. (2014) (0)
- The Prostate 68 : 1689 ^ 1695 ( 2008 ) AssociationofGeneticPolymorphismsat 8 q 24 Withthe Riskof ProstateCancer in a Japanese Population (2008) (0)
- MP12-19 SPONTANEOUS MICTURITION BEHAVIOR AND CYSTOMETRIC EVALUATION OF BLADDER FUNCTION IN P2X7 RECEPTOR DEFICIENT MICE (2015) (0)
- Pannexin 1 channels participate in urothelial ATP release and signaling. (2014) (0)
- [A case of giant perirenal malignant lymphoma: a case report]. (2002) (0)
- Abstract 2041: High-throughput chemical screening for sensitization of bladder cancer to gemcitabine and cisplatin chemotherapy (2017) (0)
- 54: Escherichia Coli from Uncomplicated and Complicated Cystitis and from Asymptomatic Bacteriuria Possess Similar Phylogeny, Virulence Genes and O Serogroup Profiles (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Osamu Ogawa?
Osamu Ogawa is affiliated with the following schools: